CACI is delighted to announce that its Certa care management platform has achieved compliance with DCB0129, the national clinical risk management standard for health and care IT software used across England.
The achievement confirms that CACI has applied the clinical risk management requirements of the standard to Certa, giving care organisations greater confidence in the platform’s use to support safe care delivery and medication management.
“Achieving DCB0129 compliance is a significant milestone for Certa,” says Ollie Watson, Group Business Development Director at CACI. “Clinical safety isn’t something we treat as a compliance exercise; it’s central to how we design and support the platform. This achievement gives care organisations assurance that Certa has been developed in line with nationally recognised clinical safety requirements, supporting them in meeting their responsibilities around safe care delivery.”
DCB0129 requires suppliers to demonstrate, through a rigorous and ongoing process, that clinical safety has been designed into a product rather than added on afterwards. For care organisations, this is particularly important where digital systems are used to support electronic medicines administration records (eMAR) and other aspects of care that can directly affect people’s health and wellbeing.
In practical terms, Certa’s compliance means CACI has appointed a qualified Clinical Safety Officer responsible for overseeing clinical risk management across the Certa’s lifecycle. CACI maintains a comprehensive hazard log, tracking potential clinical risks and the controls in place to mitigate them. CACI has also issued a formal safety case report, setting out the evidence that Certa’s clinical risks have been reduced to a level that is as low as reasonably practicable.
For care providers, this provides greater confidence when assessing a supplier’s approach to clinical safety, particularly where digital systems support medication management and care delivery. Care organisations have legal and regulatory responsibilities to ensure safe care and treatment, including the proper management and recording of medicines. Rather than asking a supplier to describe its processes, DCB0129 compliance provides documented, auditable evidence that those processes exist and are followed.
“We know that care organisations need clear evidence that clinical risks have been properly considered when evaluating digital systems” adds Watson. “By demonstrating compliance with DCB0129, we’ve addressed that concern before it becomes a barrier.
Care organisations evaluating Certa can now do so knowing that the product-level clinical risk management required of CACI as the software supplier has been completed and documented to the required standard.”
For more information, please visit the Certa webpage.
